Liletta
Device
Medicines360
Total Payments
$10.2M
Transactions
2,927
Doctors
424
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $319,750 | 58 | 8 |
| 2023 | $537,142 | 251 | 186 |
| 2022 | $708,893 | 189 | 41 |
| 2021 | $2.4M | 430 | 50 |
| 2020 | $2.0M | 396 | 25 |
| 2019 | $1.9M | 464 | 77 |
| 2018 | $1.1M | 702 | 94 |
| 2017 | $1.2M | 437 | 25 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.0M | 1,619 | 68.8% |
| Consulting Fee | $3.0M | 685 | 29.4% |
| Royalty or License | $100,000 | 1 | 1.0% |
| Travel and Lodging | $50,266 | 297 | 0.5% |
| Food and Beverage | $12,560 | 296 | 0.1% |
| Education | $6,314 | 9 | 0.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,700 | 6 | 0.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $3,040 | 6 | 0.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,594 | 5 | 0.0% |
| Honoraria | $800.00 | 1 | 0.0% |
| Grant | $750.00 | 1 | 0.0% |
| Space rental or facility fees (teaching hospital only) | $75.00 | 1 | 0.0% |
Payments by Type
Research
$7.0M
1,619 transactions
General
$3.2M
1,308 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Phase 3 multicenter, open-label study of a Levonorgestrel 52 mg Intrauterine System for the treatment of heavy Menstrual Bleeding | Medicines360 | $4.8M | 0 |
| A Study of a LevonorgestrelReleasing Intrauterine System for LongTerm, Reversible Contraception | Medicines360 | $2.2M | 0 |
Top Doctors Receiving Payments for Liletta
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Columbia, MO | $9.6M | 1,802 |
| , MD | Family Medicine | Dallas, TX | $154,359 | 32 |
| , MD | Obstetrics & Gynecology | Boston, MA | $123,893 | 28 |
| , MD | Specialist | Chevy Chase, MD | $114,430 | 6 |
| , MD | Obstetrics & Gynecology | Sacramento, CA | $32,185 | 316 |
| , M.D | Obstetrics & Gynecology | Jacksonville, FL | $13,518 | 12 |
| , M.D | Obstetrics & Gynecology | Stanford, CA | $8,400 | 1 |
| , MD | Obstetrics & Gynecology | Washington, DC | $5,671 | 18 |
| , MD | Obstetrics & Gynecology | Wilmington, NC | $5,550 | 3 |
| , MD | Obstetrics & Gynecology | Saint Louis, MO | $5,122 | 7 |
| , MD | Family Medicine | New Brunswick, NJ | $4,066 | 12 |
| , M.D | Obstetrics & Gynecology | Los Angeles, CA | $3,500 | 1 |
| , MD | Obstetrics & Gynecology | Jamaica Plain, MA | $3,325 | 3 |
| , M.D | Obstetrics & Gynecology | Houston, TX | $3,207 | 4 |
| , MD | Obstetrics & Gynecology | Norfolk, VA | $3,047 | 11 |
| , M.D | Internal Medicine | Bronx, NY | $2,725 | 3 |
| , MD | Obstetrics & Gynecology | Chicago, IL | $2,500 | 10 |
| , MD | Obstetrics & Gynecology | Chicago, IL | $2,240 | 2 |
| , MD | Infectious Disease | San Mateo, CA | $2,075 | 1 |
| , M.D | Reproductive Endocrinology | Cincinnati, OH | $1,759 | 12 |
| , MD | Obstetrics & Gynecology | Aurora, CO | $1,720 | 8 |
| James Presthus | — | Minneapolis, MN | $1,688 | 4 |
| , MD | Family Medicine | Norristown, PA | $1,635 | 3 |
| , MD | Obstetrics & Gynecology | New York, NY | $1,500 | 1 |
| , MD | Obstetrics & Gynecology | New Haven, CT | $1,500 | 6 |
Ad
Manufacturing Companies
- Medicines360 $10.2M
Product Information
- Type Device
- Total Payments $10.2M
- Total Doctors 424
- Transactions 2,927
About Liletta
Liletta is a device associated with $10.2M in payments to 424 healthcare providers, recorded across 2,927 transactions in the CMS Open Payments database. The primary manufacturer is Medicines360.
Payment data is available from 2017 to 2024. In 2024, $319,750 was paid across 58 transactions to 8 doctors.
The most common payment nature for Liletta is "Unspecified" ($7.0M, 68.8% of total).
Liletta is associated with 2 research studies, including "A Phase 3 multicenter, open-label study of a Levonorgestrel 52 mg Intrauterine System for the treatment of heavy Menstrual Bleeding" ($4.8M).